RM LAW Announces Class Action Lawsuit Against MEDNAX, Inc.

BERWYN, Pa., July 16, 2018 /PRNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased MEDNAX, Inc. ("Mednax" or the "Company") (NYSE: MD) securities between February 4, 2016 to July 27, 2017, inclusive (the "Class Period").

Mednax shareholders may, no later than September 10, 2018, move the Court for appointment as a lead plaintiff of the Class.  If you purchased shares of Mednax and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here.

The complaint alleges that during the Class Period, Mednax violated the Exchange Act by misleading investors regarding the sustainability of the Company's business model.  Throughout the Class Period, Mednax's business model depended upon growth from the acquisition of new practice groups, primarily in anesthesiology.  In truth, Mednax's business model is not sustainable and its growth was based upon suppressing physician compensation and enforcing non-compete agreements to deter physician defections.  When the truth regarding the sustainability of Mednax's business model was finally revealed at the end of the Class Period, the price of the Company's stock had declined by over 23%.

If you are a member of the class, you may, no later than September 10, 2018, request that the Court appoint you as lead plaintiff of the class.  A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation.  In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Under certain circumstances, one or more class members may together serve as "lead plaintiff."  Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff.  You may retain RM LAW, P.C. or other counsel of your choice, to serve as your counsel in this action.

For more information regarding this, please contact RM LAW, P.C.  (Richard A. Maniskas, Esquire) toll-free at (844) 291-9299 or by email at [email protected] or click here.   For more information about class action cases in general or to learn more about RM LAW, P.C. please visit our website by clicking here. 

RM LAW, P.C. is a national shareholder litigation firm.  RM LAW, P.C. is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

CONTACT: RM LAW, P.C.
Richard A. Maniskas, Esquire
1055 Westlakes Dr., Ste. 300
Berwyn, PA 19312
484-324-6800
844-291-9299
[email protected] 

SOURCE RM LAW, P.C.